Company Analysis
Sign in

Ironwood Pharmaceuticals, Inc. (IRWD)

Nasdaq: IRWD · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2008
Full chart Alerts Compare
Grade5.0
◀ Past 4.2● Present 5.0▶ Future 5.9
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedFeb 26, 2026Mar 31, 2025Feb 16, 2024Feb 16, 2023Feb 18, 2022Feb 17, 2021Feb 13, 2020Feb 25, 2019Feb 22, 2018Feb 22, 2017
Revenue296,151351,410442,735410,596413,753389,523428,413346,639298,276273,957
Cost of revenue·····3,13623,87532,75119,0971,868
Research and development95,136111,421116,08544,26570,40588,062115,044101,060r88,145r139,492
Selling, general and administrative82,256144,272158,314115,994111,133140,003172,450219,676r231,184r173,281
Total costs and expenses197,649258,2861,388,165160,259181,494246,583308,290497,309r313,639r325,827
Operating income98,50293,124-945,430250,337232,259142,940120,123-150,670r-15,363r-51,870
Interest expense32,74633,03421,6297,59831,15029,47836,60237,72436,37039,153
Interest and investment income4,0764,46818,9719,5017261,5042,8622,9912,1111,169
Other income (expense), net193640········
Total non-operating income (expense)-28,477-27,926-2,6392,085-31,602-34,079-61,180-43,476-39,552-29,838
Income before income taxes70,02565,198-948,069252,422200,657108,86158,943-194,146··
Income tax expense46,00864,31883,49077,357-327,7912,6850000
Income from continuing operations····528,448106,17658,943-194,146-54,915·
Income from discontinued operations······-37,438-88,222-62,022·
Net income including non-controlling interests24,017880-1,031,559175,065528,448106,17621,505-282,368-116,937-81,708
Net income to non-controlling interests··-29,320·······
Net income24,017880-1,002,239175,065528,448106,17621,505-282,368-116,937-81,708
Net income to common shareholders24,017880-1,002,239175,065528,448106,17621,505-282,368·-81,708
Earnings per share, basic0.150.01-6.451.133.260.670.14-1.85··
Earnings per share, diluted0.150.01-6.450.963.210.660.14-1.85··
Earnings per share, basic and diluted······0.14-1.85-0.78-0.56
Weighted average shares, basic161,842159,083155,435154,366162,245159,427156,023152,634··
Weighted average shares, diluted162,983160,084155,435186,312164,418160,655156,023152,634··
Weighted average shares, basic and diluted······156,023152,634148,993144,928
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfRevenue
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeNet
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton IRWD · research, not advice